CD4+ T-cell reconstitution predicts survival outcomes after acute graft-versus-host-disease: a dual-center validationCoco de Koning, Jaap Jan Boelens, Dorine Bresters et al.|Blood|2020Cited by 70
Improved survival with model-based dosing of antithymocyte globulin in pediatric hematopoietic cell transplantationRick Admiraal, Caroline A. Lindemans, Stefan Nierkens et al.|Blood Advances|2025Cited by 21
Excellent leukemia control after second hematopoietic cell transplants with unrelated cord blood grafts for post-transplant relapse in pediatric patientsA. Lucas, Andromachi Scaradavou, Jaap Jan Boelens et al.|Frontiers in Oncology|2023Cited by 7
Early CD4+ T-Cell Reconstitution Is an Excellent Predictor for Survival and Non-Relapse Mortality in Pediatric and Young Adult Patients Who Develop Moderate to Severe Acute Graft-Versus-Host-Disease; A Dual Center ValidationCoco de Koning, Jaap Jan Boelens, Susan E. Prockop et al.|Transplantation and Cellular Therapy|2020Cited by 3
Model-Based Dosing of Anti-Thymocyte Globulin in Pediatric Allogeneic Hematopoietic Cell Transplantation Improves Survival Chances: Updated Results from the Single Arm Phase II Parachute-Trial Combined with Real-World DataRick Admiraal, Caroline A. Lindemans, Stefan Nierkens et al.|Transplantation and Cellular Therapy|2024Cited by 2